The impact of COVID-19 on the investment environment: How are biotech and pharma adapting?

BioMelbourne Network


About the Event

At this BioForum, speaker Dr Niels Emmerich, Vice President and Global Head of Search & Evaluation at AbbVie will provide insights into the impact of the COVID-19 pandemic on the current investment environment, and how the sector is adapting to these changes. Niels leverages a deep understanding of the global pharma deal landscape, having held the position of Head of Oncology Search & Evaluation at AbbVie from 2014-18, and now leads a global team. He has overseen several strategic acquisitions that transformed AbbVie's pipeline, and has driven licensing, venture and research collaborations with numerous biotech companies.